Advertisement
Screener

Perrigo Company plc (PRGO) Expense Breakdown

Perrigo Company plc Expense Breakdown

No Expense Breakdown for PRGO on this site yet.

  • 2026-06-27: Self Care $402.30M; Specialty Care $106.10M; Infant Formula $80.20M.
  • 2025-06-28: Self Care $397.10M; Specialty Care $98.10M; Infant Formula $71.20M.

Source checked: the stored Expense Breakdown page for PRGO.

Expenses by product

Cost of sales: each quarter (3 month)

Quarter endSelf CareSpecialty CareInfant Formula
2026-06-27$402.30M$106.10M$80.20M
2025-06-28$397.10M$98.10M$71.20M

Operating expenses: each quarter (3 month)

Quarter endSelf CareSpecialty CareInfant Formula
2026-06-27$95.60M$72.70M$16.80M
2025-06-28$107.60M$68.70M$23.00M

Restructuring Charges: each quarter (3 month)

Quarter endSelf CareSpecialty CareInfant Formula
2026-06-27$800.00K$3.80M$14.80M
2025-06-28$3.80M$1.20M$1.20M

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
Generate Biomedicines, Inc. (GENB)United States$2.052B
UroGen Pharma Ltd. (URGN)$2.015B-18.42
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12
Biohaven Ltd. (BHVN)United States$1.990B-3.83
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Braveheart Bio, Inc. (BRVE)United States$2.106B
Bausch Health Companies Inc. (BHC)$2.113B-1.68
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38